336 filings
8-K
PCRX
Pacira BioSciences Inc
8 May 24
Pacira BioSciences, Inc. Announces Proposed Offering of $250.0 Million Aggregate Principal Amount of Convertible Senior Notes
4:13pm
10-Q
2024 Q1
PCRX
Pacira BioSciences Inc
Quarterly report
7 May 24
4:02pm
8-K
PCRX
Pacira BioSciences Inc
7 May 24
Pacira BioSciences Reports First Quarter 2024 Financial Results
4:01pm
ARS
2023 FY
PCRX
Pacira BioSciences Inc
22 Apr 24
Annual report to shareholders
4:20pm
DEFA14A
PCRX
Pacira BioSciences Inc
22 Apr 24
Additional proxy soliciting materials
4:17pm
S-8
28430
29 Feb 24
Registration of securities for employees
5:29pm
8-K
zb85ygd
29 Feb 24
Pacira BioSciences Reports Fourth Quarter and Full-Year 2023 Financial Results
8:03am
8-K
yke7k11tq0lyjuf0w7k5
4 Jan 24
Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2023 Revenues
5:02pm
8-K
x3fx xtvbgiginacj5s
21 Dec 23
Pacira Appoints Frank D. Lee as Chief Executive Officer
7:33am
8-K
qlkg 3q33fq
2 Nov 23
Pacira BioSciences Reports Third Quarter 2023 Financial Results
8:01am
UPLOAD
7cpv wpd1kv5266t
24 Oct 23
Letter from SEC
12:00am
8-K
zpj5voeu
10 Oct 23
Pacira BioSciences Appoints Four New Independent Directors to its Board of Directors
8:02am
CORRESP
pesfl899zzlgv
6 Oct 23
Correspondence with SEC
12:00am
8-K
2m140puihjmct9vp9 1s
26 Sep 23
Pacira BioSciences Announces Leadership Succession Plan
4:32pm
UPLOAD
dmiql
22 Sep 23
Letter from SEC
12:00am
8-K
j0ryi5m okbd1vus
11 Sep 23
Other Events
4:27pm
S-8
nlwuatji9
2 Aug 23
Registration of securities for employees
4:34pm